Description

Each vial from Owens Peptide Solutions contains 10mg of lyophilized Ipamorelin for qualified scientific research. The peptide is composed of five amino-acid-derived components and carries the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2.

Research Use Disclaimer:

For laboratory and research use only. Not intended for human or animal consumption, medical use, diagnostic use, veterinary use, or therapeutic application.

Ipamorelin was developed as a selective growth hormone secretagogue associated with activity at the growth hormone secretagogue receptor. Laboratory investigations have examined receptor selectivity, somatotroph signaling, endocrine response timing, and experimental growth hormone release patterns. Additional preclinical work has considered its relationship with ghrelin-associated gastrointestinal pathways.

Available findings vary according to the selected research model and should not be interpreted as confirmed clinical outcomes.